Patrick M. Kelley

Patrick M. Kelley

Auto-generated profile, based on publicly available information

Patrick M. Kelley

Department of Biological Sciences, Wayne State University, Detroit, MI, 48202, USA

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
David NjusDavid Njus
David Njus
PKPatrick M. Kelley
Patrick M. Kelley
YTYi-Jung Tu
Yi-Jung Tu
HSH. Bernhard Schlegel
H. Bernhard Schlegel

1 November 1990 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PKP M Kelley
P M Kelley
VJV Jalukar
V Jalukar
David NjusDavid Njus
David Njus
Cytochrome b561 transfers electrons across secretory vesicle membranes in order to regenerate intravesicular ascorbic acid. To show that cytosolic ascorbic acid is kinetically competent to function as the external electron donor for this process, electron transfer rates between cytochrome b561 in adrenal medullary chromaffin vesicle membranes and external ascorbate/semidehydroascorbate were measured. The reduction of cytochrome b561 by external ascorbate may be measured by a stopped-flow method. The rate constant is 450 (+/- 190) M-1 s-1 at pH 7.0 and increases slightly with pH. The rate of oxidation of cytochrome b561 by external semidehydroascorbate may be deduced from rates of steady-state electron flow. The rate constant is 1.2 (+/- 0.5) x 10(6) M-1 s-1 at pH 7.0 and decreases strongly with pH. The ratio of the rate constants is consistent with the relative midpoint reduction potentials of cytochrome b561 and ascorbate/semidehydroascorbate. These results suggest that cytosolic ascorbate will reduce cytochrome b561 rapidly enough to keep the cytochrome in a mostly reduced state and maintain the necessary electron flux into vesicles. This supports the concept that cytochrome b561 shuttles electrons from cytosolic ascorbate to intravesicular semidehydroascorbate, thereby ensuring a constant source of reducing equivalents for intravesicular monooxygenases.